scholarly journals DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response

2014 ◽  
Vol 1 ◽  
pp. 14054 ◽  
Author(s):  
Trevor RF Smith ◽  
Katherine Schultheis ◽  
William B Kiosses ◽  
Dinah H Amante ◽  
Janess M Mendoza ◽  
...  
2012 ◽  
Vol 80 (3) ◽  
pp. 1128-1139 ◽  
Author(s):  
Chaniya Leepiyasakulchai ◽  
Lech Ignatowicz ◽  
Andrzej Pawlowski ◽  
Gunilla Källenius ◽  
Markus Sköld

Susceptibility toMycobacterium tuberculosisis characterized by excessive lung inflammation, tissue damage, and failure to control bacterial growth. To increase our understanding of mechanisms that may regulate the host immune response in the lungs, we characterized dendritic cells expressing CD103 (αEintegrin) (αE-DCs) and CD4+Foxp3+regulatory T (Treg) cells duringM. tuberculosisinfection. In resistant C57BL/6 and BALB/c mice, the number of lung αE-DCs increased dramatically duringM. tuberculosisinfection. In contrast, highly susceptible DBA/2 mice failed to recruit αE-DCs even during chronic infection. Even though tumor necrosis factor alpha (TNF-α) is produced by multiple DCs and macrophage subsets and is required for control of bacterial growth, αE-DCs remained TNF-α negative. Instead, αE-DCs contained a high number of transforming growth factor beta-producing cells in infected mice. Further, we show that Tregcells in C57BL/6 and DBA/2 mice induce gamma interferon during pulmonary tuberculosis. In contrast to resistant mice, the Tregcell population was diminished in the lungs, but not in the draining pulmonary lymph nodes (PLN), of highly susceptible mice during chronic infection. Tregcells have been reported to inhibitM. tuberculosis-specific T cell immunity, leading to increased bacterial growth. Still, despite the reduced number of lung Tregcells in DBA/2 mice, the bacterial load in the lungs was increased compared to resistant animals. Our results show that αE-DCs and Tregcells that may regulate the host immune response are increased inM. tuberculosis-infected lungs of resistant mice but diminished in infected lungs of susceptible mice.


2012 ◽  
Vol 181 (4) ◽  
pp. 1327-1337 ◽  
Author(s):  
Daniela Schindler ◽  
Maximiliano G. Gutierrez ◽  
Andreas Beineke ◽  
Yvonne Rauter ◽  
Manfred Rohde ◽  
...  

2015 ◽  
Vol 9 (12) ◽  
pp. e0004234 ◽  
Author(s):  
Ernesto Rodríguez ◽  
Verónica Noya ◽  
Laura Cervi ◽  
María Laura Chiribao ◽  
Natalie Brossard ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Chenlu Liu ◽  
Xianling Cong ◽  
Yuqian Wang ◽  
Qianqian Guo ◽  
Yu Xie ◽  
...  

Conventional DNA vaccine strategies usually employ a regimen of immunizations at 2-week or longer intervals to induce effective memory cell-dependent immune responses. Clinical cancer treatment requires a faster immunization strategy to contend with tumor progression. In this study, a novel fast immunization strategy was established, wherein a DNA vaccine was intramuscularly administered on days 0, 2, and 5 in a murine lung cancer model. Effector cells peaked 7 to 10 days after the last vaccination. Compared with traditional 2-week-interval immunization strategies, antigen-specific cytolysis and INF-γ secretion were significantly enhanced under the fast vaccination approach. As a result, the rapidly administered DNA vaccine elicited stronger and more prompt antitumor effects. The probable underlying mechanism of fast immunization was the accumulation of CD8+CD11c+ antigen-presenting cells at the injection site, which enhanced subsequent antigen presentation. In conclusion, the fast DNA vaccination strategy shortened vaccination time to 5 days and elicited a stronger antitumor immune response.


Sign in / Sign up

Export Citation Format

Share Document